Pseudoephedrine: 1. Synonyms CFR: Nist #
Pseudoephedrine: 1. Synonyms CFR: Nist #
Pseudoephedrine: 1. Synonyms CFR: Nist #
OH
C CH 3
H H
C
HN
CH 3
1. SYNONYMS
CFR: Pseudoephedrine
(1S,2S)-2-Methylamino-1-phenylpropan-1-ol
d--Ephedrine
d-Isoephedrine
2.2. SOLUBILITY
Form A C E H M W
Bismuth iodide in diluted H2SO4 Hanging drop, volatility Orange-red rhomboids, sticks,
forms readily
Visualization
adrenaline 0.0
ephedrine 0.8
methamphetamine 0.9
pseudoephedrine 1.0
amphetamine 1.2
cathine 1.2
phenylpropanolamine 1.3
caffeine 1.5
3.4. GAS CHROMATOGRAPHY/MASS SPECTROMETRY (GC/MS)
Method PSE-GCMS1
Samples are dissolved in an appropriate solvent (i.e. methanol, chloroform/base extract) and filtered prior to
injection.
Method PSE-IRDS1
Note: Reference the RRT from GC section 3.4 as listed above as this parameter is column dependent.
4. SEPARATION TECHNIQUES
Pseudoephedrine hydrochloride can be isolated from several adulterants and diluents as well as several
controlled substances by the use of solvent extractions. For example, pseudoephedrine hydrochloride can be
separated from common tablet excipients by performing a chloroform extraction of the mixture.
Pseudoephedrine will dissolve in the chloroform extract, leaving behind the tableting material.
5. QUANTITATIVE PROCEDURES
Sample Preparation:
In a volumetric flask, accurately weigh and prepare a sample solution of pseudoephedrine hydrochloride at a
target concentration of 1.6 mg/mL in 1 part methanol, 1 part internal standard stock solution, and 3 parts
chloroform. Add an appropriate amount of 5 N NaOH directly into the flask and shake vigorously to ensure
that all pseudoephedrine hydrochloride is dissolved. Check pH to ensure a pH ~14. Vortex and centrifuge if
necessary. Remove the bottom layer and filter through a cotton-plugged pipette or other appropriate filtering
device into an autosampler vial.
Note 1: Although pseudoephedrine readily dissolves in methanol, its solubility in chloroform is limited; and in
many instances, matrix effects can be problematic. Therefore, the entire sample solution must be base extracted
with 5 N NaOH.
Note 2: The pKa of pseudoephedrine hydrochloride is 9.22. Use of a concentrated sodium hydroxide solution
(pH ~14) is necessary to ensure complete conversion of the pseudoephedrine hydrochloride into the base, with
subsequent extraction into the organic chloroform layer. Running pseudoephedrine (and other
phenethylamines) as the base strongly recommended. Failure to do so will result in poor chromatographic peak
shape due to the interaction of the amine salts with the stationary phase of the column. DO NOT USE sodium
carbonate or sodium bicarbonate solutions to extract the pseudoephedrine as the pH of these solutions is not
sufficiently high to fully convert the hydrochloride to the base form and extract the base into the chloroform
layer. In cases of strongly acidic liquids, a higher normality of NaOH may be required to obtain a pH of 14.
Note 3: Triprolidine and chlorpheniramine are common adulterants in tablets. These compounds will not elute
under the isothermal conditions before the 7 minute time elapses. If these compounds are present in a sample,
the temperature should be ramped after 7 minutes and held until these compounds elute.
PMMA 1.53
5.2. HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
Method PSE-LCQ1
Note 1: Although pseudoephedrine readily dissolves in the 0.1 N HCl solution, sugars, inorganic salts, and
some of the more common tablet excipients are insoluble. This may require additional sonication time in order
to release all of the pseudoephedrine from the excipient matrix.
Note 2: Resolution between pseudoephedrine and ephedrine is less than the 1.5 critical value necessary for
accurate quantitation if both compounds are present. Do NOT use this method for quantitation if both
ephedrine and pseudoephedrine are present.
Note 3: Triprolidine does not elute under these conditions. A gradient ramp to buffer:ACN (50:50) must be
added to the end of the method in order to elute triprolidine.
6. QUALITATIVE DATA
See spectra on the following pages for FT-IR, Raman, ATR, Mass Spectrometry, Nuclear Magnetic Resonance,
Vapor Phase IR, GC/MS-TPC, and CD-ORD results.
7. REFERENCES
Budavari, S., The Merck Index, 13th Edition, Merck and Co., Inc., 2001, pgs. 1416-1417.
Fulton C. C., Modern Microcrystal Tests for Drugs, Wiley-Interscience, New York, 1969, pgs. 204-205.
Moffat A. C., Sr. Ed., Clarke's Isolation and Identification of Drugs, The Pharmaceutical Press, London,
Second Edition, 1996, pgs. 944-945.
8. ADDITIONAL RESOURCES
Forendex
Wikipedia
FTIR (ATR): Pseudoephedrine hydrochloride
16 scans, 2 cm-1 resolution, range 4000-600
100
95
90
85
%R eflectance
80
75
70
65
60
95
90
85
80
75
%R eflectance
70
65
60
55
50
45
40
35
90
80
70
60
%T 50
40
30
20
8.0
4000.0 3000 2000 1500 1000 400.0
cm-1
90
80
70
60
%T 50
40
30
20
8.0
4000.0 3000 2000 1500 1000 400.0
cm-1
FT RAMAN: Pseudoephedrine hydrochloride
64 scans, 8 cm-1 resolution range 3700-410
6.0
5.5
5.0
4.5
4.0
R aman intensity
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0.0
3000 2000 1500 1000 500
Raman shift (cm-1)
5.5
5.0
4.5
4.0
R aman intensity
3.5
3.0
2.5
2.0
1.5
1.0
0.5
MS (EI): Pseudoephedrine
Abundance
3500000
3000000
2500000
2000000
1500000
1000000
500000
77
42 51
65 71 85 91 98 105 117 132 146 166
0
40 50 60 70 80 90 100 110 120 130 140 150 160 170
m/z-->
GC/MS-TPC: d,l-Pseudoephedrine
chloroform, base extracted with 5 N NaOH, C-4 (time reference), TPC reagent
Abundance
TIC: DLPSDT.D
3000000
2800000
2600000
2400000
2200000
2000000
1800000
1600000
1400000
1200000
1000000
800000
600000
400000
200000
1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 5.50 6.00 6.50 7.00 7.50
Time-->
Abundance
8000 l-Pseudoephedrine
6000
4000
2000 251
42 77 96 148
117 133 194
179 207 224 273 289 340
0
40 60 80 100 120 140 160 180 200 220 240 260 280 300 320 340
m/z-->
Abundance
8000 d-Pseudoephedrine
6000
4000
2000 252
42 77 96
117 133148 194
207 224 273 289 341
0
40 60 80 100 120 140 160 180 200 220 240 260 280 300 320 340
m/z-->
1.0 No. (ppm)
1 1.08
FT-NMR 100 MHz Proton (TMS)
0.9 2 1.10
3 2.73
Pseudoephedrine Hydrochloride
4 3.34 in CD3OD (20 mg/mL)
0.8 5 3.36
6 3.37
0.7 7 3.38
8 4.57
Normalized Intensity
9 4.59
0.6 10 4.89
11 7.34
0.5 12 7.35
13 7.36
14 7.38
0.4
15 7.40
16 7.42
0.3 17 7.44
0.2
0.1
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
11 74.35
0.6 12 127.08
13 128.58
14 128.66
0.5
15 140.73
0.4
0.3
0.2
0.1
9 4.29
0.6 10 4.91
11 4.91
0.5 12 7.26
13 7.27
14 7.28
0.4 15 7.29
16 7.33
0.3 17 7.34
0.2
0.1
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
Chemical Shift (ppm)
No. (ppm)
1.0 1 13.89
FT-NMR 100 MHz Carbon (TMS) 2 32.17
0.9 Pseudoephedrine Base 3 47.21
4 47.42
in CD3OD (110 mg/mL) 5 47.63
0.8 6 47.85
7 48.06
0.7 8 48.27
9 48.49
10 60.78
Normalized Intensity
0.6 11 77.60
12 127.07
0.5 13 127.65
14 128.19
15 142.79
0.4
0.3
0.2
0.1